Literature DB >> 21249040

Malaria prophylaxis.

F P Scappatura, D Lawee, E Gutman.   

Abstract

The authors of this paper provide an overview of the relative risk of malaria in various areas of the world. On the basis of the geographic information available, they discuss both chemoprophylaxis and treatment for this disease, and make recommendations for their use.

Entities:  

Year:  1989        PMID: 21249040      PMCID: PMC2280832     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  7 in total

1.  Mefloquine resistance of falciparum malaria from Tanzania enhanced by treatment.

Authors:  I C Bygbjerg; A Schapira; H Flachs; G Gomme; S Jepsen
Journal:  Lancet       Date:  1983-04-02       Impact factor: 79.321

2.  Type II mefloquine resistance in Thailand.

Authors:  E F Boudreau; H K Webster; K Pavanand; L Thosingha
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

3.  Prevention and treatment of malaria.

Authors:  G C Cook
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

4.  RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.

Authors:  S L Hoffman; D Rustama; A J Dimpudus; N H Punjabi; J R Campbell; H S Oetomo; H A Marwoto; S Harun; N Sukri; P Heizmann
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

5.  Quinine and severe falciparum malaria in late pregnancy.

Authors:  S Looareesuwan; R E Phillips; N J White; S Kietinun; J Karbwang; C Rackow; R C Turner; D A Warrell
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

6.  Doxycycline prophylaxis for falciparum malaria.

Authors:  L W Pang; N Limsomwong; E F Boudreau; P Singharaj
Journal:  Lancet       Date:  1987-05-23       Impact factor: 79.321

7.  Treatment of chloroquine-resistant malaria during pregnancy.

Authors:  E K Main; D M Main; D J Krogstad
Journal:  JAMA       Date:  1983-06-17       Impact factor: 56.272

  7 in total
  1 in total

1.  Malaria prophylaxis.

Authors:  R C Wittes
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.